Intec Pharma (NTEC) Short Interest Ratio & Short Volume → You need to know these two things about AI stocks ASAP… (From InvestorPlace) (Ad) Free NTEC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Intec Pharma Short Interest DataCurrent Short Volume755,300 sharesPrevious Short Volume529,000 sharesChange Vs. Previous Month+42.78%Dollar Volume Sold Short$2.54 millionShort Interest Ratio / Days to Cover0.5Last Record DateJuly 15, 2021Outstanding Shares898,000 sharesFloat Size4,690,000 sharesShort Percent of Float16.10%Today's Trading Volume988,300 sharesAverage Trading Volume543,436 sharesToday's Volume Vs. Average182% Short Selling Intec Pharma ? Sign up to receive the latest short interest report for Intec Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNTEC Short Interest Over TimeNTEC Days to Cover Over TimeNTEC Percentage of Float Shorted Over Time Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Intec Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2021755,300 shares $2.54 million +42.8%16.1%0.5 $3.36 6/30/2021529,000 shares $1.84 million +92.5%11.3%0.4 $3.47 6/15/2021274,800 shares $1.07 million -39.8%5.9%0.2 $3.90 5/28/2021456,200 shares $1.72 million -8.3%9.7%0.5 $3.77 5/14/2021497,500 shares $1.72 million +39.8%10.6%0.5 $3.46 4/30/2021355,900 shares $1.47 million -31.9%8.1%0.3 $4.12 Get the Latest News and Ratings for NTEC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Intec Pharma and its competitors with MarketBeat's FREE daily newsletter. 4/15/2021522,900 shares $2.12 million -13.7%12.0%0.7 $4.06 3/31/2021606,000 shares $2.53 million +5.9%13.9%0.6 $4.18 3/15/2021572,500 shares $2.63 million +5.0%14.1%0.6 $4.59 2/26/2021545,500 shares $2.62 million +5.5%15.3%0.5 $4.80 2/12/2021517,100 shares $3.44 million +1.2%14.5%0.4 $6.66 1/29/2021511,100 shares $2.18 million +4.2%14.4%0.5 $4.27 1/15/2021490,600 shares $2.13 million +283.9%13.6%0.5 $4.34 12/31/2020127,800 shares $469,026.00 -61.3%3.6%0.1 $3.67 12/15/2020330,400 shares $1.37 million +191.6%9.2%0.4 $4.14 11/30/2020113,300 shares $368,225.00 -18.4%3.2%0.2 $3.25 11/15/2020138,800 shares $466,368.00 +14.4%3.9%0.7 $3.36 10/30/2020121,300 shares $18,655.94 -96.2%3.4%0.5 $0.15 10/15/20203,200,000 shares $16.26 million -1.5%N/A0.7 $5.08 9/30/20203,250,000 shares $16.35 million +0.3%N/A0.4 $5.03 9/15/20203,240,000 shares $18.67 million +8.0%N/A0.5 $5.76 8/31/20203,000,000 shares $18.48 million -27.2%N/A0.4 $6.16 8/14/20204,120,000 shares $30.49 million -16.4%N/A0.4 $7.40 7/31/20204,930,000 shares $41.28 million +178.5%N/A0.5 $8.37 7/15/20201,770,000 shares $10.75 million -23.4%N/A0.2 $6.07 6/30/20202,310,000 shares $13.31 million -19.5%N/A0.3 $5.76 6/15/20202,870,000 shares $21.37 million +170.8%N/A0.4 $7.45 5/29/20201,060,000 shares $6.08 million +278.7%N/A0.1 $5.74 5/15/2020279,900 shares $1.22 million +777.4%N/A0 $4.35 4/30/202031,900 shares $159,500.00 -60.8%N/A0 $5.00 4/15/202081,300 shares $353,492.40 +124.0%N/A0 $4.35 3/31/202036,300 shares $9,075.00 -90.3%N/A0 $0.25 3/13/2020374,100 shares $78,561.00 -38.2%N/A0.1 $0.21 2/28/2020605,000 shares $108,900.00 -25.0%N/A0.3 $0.18 2/14/2020807,100 shares $201,775.00 -7.7%N/A0.8 $0.25 1/31/2020874,300 shares $236,061.00 -6.4%N/A1.1 $0.27 1/15/2020934,200 shares $261,576.00 +25.9%3.2%2 $0.28 12/31/2019741,800 shares $385,736.00 -6.8%2.5%1.7 $0.52 NTEC Short Interest - Frequently Asked Questions What is Intec Pharma's current short interest? Short interest is the volume of Intec Pharma shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 755,300 shares of NTEC short. 16.10% of Intec Pharma's shares are currently sold short. Learn More on Intec Pharma's current short interest. What is a good short interest percentage for Intec Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.10% of Intec Pharma's floating shares are currently sold short. Is Intec Pharma's short interest increasing or decreasing? Intec Pharma saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 755,300 shares, an increase of 42.8% from the previous total of 529,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Intec Pharma's float size? Intec Pharma currently has issued a total of 898,000 shares. Some of Intec Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Intec Pharma currently has a public float of 4,690,000 shares. How does Intec Pharma's short interest compare to its competitors? 16.10% of Intec Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Intec Pharma: Virios Therapeutics, Inc. (1.11%), eFFECTOR Therapeutics, Inc. (7.16%), NuCana plc (0.50%), Addex Therapeutics Ltd (2.74%), Biofrontera Inc. (1.20%), Bionomics Limited (2.03%), Cyclerion Therapeutics, Inc. (1.03%), Chemomab Therapeutics Ltd. (1.31%), Tenax Therapeutics, Inc. (1.88%), ASLAN Pharmaceuticals Limited (1.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($7.55 billion), Block, Inc. ($7.47 billion), S&P Global Inc. ($7.40 billion), Analog Devices, Inc. ($6.82 billion), Aon plc ($5.98 billion), Charter Communications, Inc. ($5.10 billion), Wayfair Inc. ($4.38 billion), AMC Entertainment Holdings, Inc. ($2.87 billion), Teladoc Health, Inc. ($2.55 billion), and Nuance Communications, Inc. ($2.41 billion). View all of the most shorted stocks. What does it mean to sell short Intec Pharma stock? Short selling NTEC is an investing strategy that aims to generate trading profit from Intec Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Intec Pharma? A short squeeze for Intec Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NTEC, which in turn drives the price of the stock up even further. How often is Intec Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NTEC, twice per month. The most recent reporting period available is July, 15 2021. More Short Interest Resources from MarketBeat Related Companies: VIRI Short Squeeze EFTR Short Squeeze NCNA Short Squeeze ADXN Short Squeeze BFRI Short Squeeze BNOX Short Squeeze CYCN Short Squeeze CMMB Short Squeeze TENX Short Squeeze ASLN Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NTEC) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin Analytics